Risk of bowel perforation in patients receiving interleukin-2 after therapy with anti-CTLA 4 monoclonal antibody.

Journal Article (Letter)

Full Text

Duke Authors

Cited Authors

  • Smith, FO; Goff, SL; Klapper, JA; Levy, C; Allen, T; Mavroukakis, SA; Rosenberg, SA

Published Date

  • January 1, 2007

Published In

Volume / Issue

  • 30 / 1

Start / End Page

  • 130 -

PubMed ID

  • 17198092

Pubmed Central ID

  • PMC2151199

International Standard Serial Number (ISSN)

  • 1524-9557

Digital Object Identifier (DOI)

  • 10.1097/01.cji.0000211334.06762.89

Language

  • eng

Conference Location

  • United States